Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer
- PMID: 40102930
- PMCID: PMC11917039
- DOI: 10.1186/s12967-025-06376-8
Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer
Abstract
Background: Gastric cancer is a highly aggressive malignancy characterized by a complex tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs), which are a key component of the TME, exhibit significant heterogeneity and play crucial roles in tumor progression. Therefore, a comprehensive understanding of CAFs is essential for developing novel therapeutic strategies for gastric cancer.
Methods: This study investigates the characteristics and functional information of CAF subtypes and explores the intercellular communication between CAFs and malignant epithelial cells (ECs) in gastric cancer by analyzing single-cell sequencing data from 24 gastric cancer samples. CellChat was employed to map intercellular communication, and Seurat was used to integrate single-cell sequencing data with spatial transcriptome data to reconstruct a comprehensive single-cell spatial map. The spatial relationship between apCAFs and cancer cells was analyzed using multicolor immunohistochemistry.
Results: Cells were categorized into nine distinct categories, revealing a positive correlation between the proportions of epithelial cells (ECs) and fibroblasts. Furthermore, six fibroblast subpopulations were identified: inflammatory (iCAFs), pericytes, matrix (mCAFs), antigen-presenting (apCAFs), smooth muscle cells (SMCs), and proliferative CAFs (pCAFs). Each of these subpopulations was linked to various biological processes and immune responses. Malignant ECs exhibited heightened intercellular communication, particularly with CAF subpopulations, through specific ligand-receptor interactions. High-density regions of CAF subpopulations displayed spatial exclusivity, with pericytes serving as a source for iCAFs, mCAFs, and apCAFs. Notably, malignant ECs and apCAFs showed increased interactions, with certain ligand-receptor pairs potentially impacting the prognosis of gastric cancer. Multiplex immunohistochemistry (mIHC) confirmed the close spatial proximity of apCAFs to cancer cells in gastric cancer.
Conclusion: Our study provided a comprehensive characterization of CAF heterogeneity in gastric cancer and revealed the intricate intercellular networks within the TME. The identified CAF subpopulations and their interactions with malignant cells could serve as potential therapeutic targets.
Keywords: Cancer-associated fibroblasts; Cell–cell interactions; Gastric cancer; Single-cell transcriptomics; Tumor microenvironment.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the ethics committee of affiliated cancer hospital of Zhengzhou University (2021-KY-0012-001) and conducted in accordance with the Declaration of Helsinki. All subjects gave written informed consent before participating in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases.Sci Rep. 2025 Jan 17;15(1):2217. doi: 10.1038/s41598-025-85531-z. Sci Rep. 2025. PMID: 39820531 Free PMC article.
-
Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.Theranostics. 2022 Jan 1;12(2):620-638. doi: 10.7150/thno.60540. eCollection 2022. Theranostics. 2022. PMID: 34976204 Free PMC article.
-
A multi-omics atlas of CAF subtypes reveals apCAF-M2 macrophage interactions driving immune resistance in glioma.PLoS One. 2025 Aug 11;20(8):e0329801. doi: 10.1371/journal.pone.0329801. eCollection 2025. PLoS One. 2025. PMID: 40788933 Free PMC article.
-
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy.Cancer Metastasis Rev. 2024 Sep;43(3):1095-1116. doi: 10.1007/s10555-024-10186-7. Epub 2024 Apr 11. Cancer Metastasis Rev. 2024. PMID: 38602594 Free PMC article. Review.
-
Targeting the devil: Strategies against cancer-associated fibroblasts in colorectal cancer.Transl Res. 2024 Aug;270:81-93. doi: 10.1016/j.trsl.2024.04.003. Epub 2024 Apr 16. Transl Res. 2024. PMID: 38614213 Review.
Cited by
-
Dynamic monitoring and multi-pathway regulation of FBXO21 in renal clear cell carcinoma: from static marker to perspective of precision therapy.J Transl Med. 2025 Apr 11;23(1):429. doi: 10.1186/s12967-025-06411-8. J Transl Med. 2025. PMID: 40217289 Free PMC article. No abstract available.
-
Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies.Front Oncol. 2025 Jun 23;15:1596947. doi: 10.3389/fonc.2025.1596947. eCollection 2025. Front Oncol. 2025. PMID: 40626005 Free PMC article. Review.
-
Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.Front Immunol. 2025 May 29;16:1595070. doi: 10.3389/fimmu.2025.1595070. eCollection 2025. Front Immunol. 2025. PMID: 40510364 Free PMC article. Review.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. - PubMed
-
- Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48. - PubMed
-
- Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin Cancer Biol. 2022;86:566–82. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical